CORONARY VENOUS SYSTEM DISEASES

Coronary_Venous_System_Diseases

CORONARY VENOUS DISEASES

Ercan Akşit1 Sumit Verma2

1Çanakkale Onsekiz Mart University, Faculty of Medicine, Department of Cardiology, Çanakkale, Türkiye
2Heart Rhythm Center, Baptist Heart and Vascular Institute, Department of Cardiology, Pensacola, Florida, USA

Akşit E, Verma S. Coronary Venous Disease. In: Altay S, Akşit E, Kemaloğlu Öz T editor. Coronary Venous System Diseases. 1st ed. Ankara: Türkiye Klinikleri; 2025. p73-83.

ABSTRACT

Since the coronary venous system serves as a guide in electrophysiology and is the place where devic- es such as coronary sinus reducers are implanted, it is very important to understand this large system anatomically as well as to know which pathologies it causes. There are many valves in the coronary venous system other than the Thebesian and Vieussen valves, and it has been previously shown that they are functional. Since it is known that these valves are not present in some patients, it has been experimentally tested whether the pressure in the coronary venous system causes damage to the myo- cardial tissue. It has been shown that the myocardial tissue is damaged in the model where coronary vein ligation is performed. It has also been previously shown that coronary sinus reflux is associated with coronary slow flow in some cases. Moreover, our article includes cases in which a myocardial venous bridge was detected during venography in which coronary sinus reverse flow was demonstrated in patients with severe heart failure. In the light of this information, the aim of this section is to address coronary venous diseases in a holistic manner for the first time.

Keywords: Coronary venous diseases; Coronary venous system; Thebesian valve; Venous occlusion; Venous insufficiency

Referanslar

  1. Martin SS, Aday AW, Almarzooq ZI, Cheryl AM, Anderson CAM, Arora P, Avery C, et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association [published correction appears in Circulation. 2024;149(8):e347-e913. [Crossref]
  2. Krishna BA, Metaxaki M, Sithole N, Landín P, Martín P, Salinas-Botrán A. Cardiovascular disease and covid-19: A sys tematic review. Int J Cardiol Heart Vasc. 2024;54:101482. [Crossref]  [PubMed]  [PMC]
  3. Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, et al. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015. J Am Coll Cardiol. 2017;70:1-25. [Crossref]  [PubMed]  [PMC]
  4. Halliday BP, Cleland JGF, Goldberger JJ, Prasad SK. Per Akşit, Verma Coronary Venous Diseases sonalizing risk stratification for sudden death in dilated cardiomyopathy: the past, present, and future. Circulation. 2017;136:215-31. [Crossref]  [PubMed]  [PMC]
  5. Karam N, Bataille S, Marijon E, Taflet M, Benamer H, Caussin C, et al. Incidence, Mortality, and Outcome-Predictors of Sudden Cardiac Arrest Complicating Myocardial Infarction Prior to Hospital Admission. Circ Cardiovasc Interv. 2019;12(1):e007081. [Crossref]  [PubMed]
  6. Koivunen M, Tynkkynen J, Oksala N, Eskola M, Hernesniemi J. Incidence of sudden cardiac arrest and sudden cardiac death after unstable angina pectoris and myocardial infarction. Am Heart J. 2023;257:9-19. [Crossref]  [PubMed]
  7. Srinivasan NT, Schilling RJ. Sudden Cardiac Death and Arrhythmias. Arrhythm Electrophysiol Rev. 2018;7(2):111-117. [Crossref]  [PubMed]
  8. Sirajuddin A, Chen MY, White CS, Arai AE. Coronary venous anatomy and anomalies. J Cardiovasc Comput Tomogr. 2020;14(1):80-6. [Crossref]  [PubMed]
  9. Moura RM, Gonçalves GS, Navarro TP, Britto RR, Dias RC. Relationship between quality of life and the CEAP clinical classification in chronic venous disease. Rev Bras Fisioter. 2010;14(2):99-105. [Crossref]  [PubMed]
  10. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130(4):333-46. [Crossref]  [PubMed]
  11. Mansilha A, Sousa J. Pathophysiological mechanisms of chronic venous disease and implications for venoactive drug therapy. Int J Mol Sci. 2018; 19: e1669. [Crossref]  [PubMed]  [PMC]
  12. Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contributing role of iron accumulation in progression of the disease. Arch Dermatol. 1988; 124:1376-8. [Crossref]  [PubMed]
  13. Santler B, Goerge T. Chronic venous insufficiency a review of pathophysiology, diagnosis, and treatment. J Dtsch Dermatol Ges. 2017;15(5):538-56. [Crossref]
  14. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006; 99:589-93. [Crossref]  [PubMed]  [PMC]
  15. Zamboni P, Galeotti R, Menegatti E, Malagoni AM, Gianesini S, Bartolomei I, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency [published correction appears in J Vasc Surg. 2010 Apr;51(4):1079]. J Vasc Surg. 2009;50(6):1348-58. e583. [Crossref]  [PubMed]
  16. Zamboni P, Galeotti R. The chronic cerebrospinal venous insufficiency syndrome. Phlebology. 2010;25:269-79. [Crossref]  [PubMed]
  17. Porto G, De Sousa M. Iron overload and immunity. World J Gastroenterol. 2007;13:4707-15. [Crossref]  [PubMed]  [PMC]
  18. Zakaria et al. Failure of the vascular hypothesis of multiple sclerosis in a rat model of chronic cerebrospinal venous insufficiency. Folia Neuropathol. 2017;55(1):49-59. [Crossref]  [PubMed]
  19. Lee BC, Tsai HH, Liu CJ, Chen YF, Tsai LK, Jeng JS, et al. Cerebral Venous Reflux and Cerebral Amyloid Angiopathy: An Magnetic Resonance Imaging/Positron Emission Tomography Study. Stroke. 2023;54(4):1046-1055. [Crossref]  [PubMed]
  20. Chung CP, Hsu HY, Chao AC, Sheng WY, Soong BW, Hu HH. Transient global amnesia: cerebral venous outflow impairment-insight from the abnormal flow patterns of the internal jugular vein. Ultrasound Med Biol. 2007;33(11):17271735. [Crossref]  [PubMed]
  21. Altamura S, Muckenthaler MU. Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. J Alzheimer Dis. 2009;16:879-95. [Crossref]  [PubMed]
  22. Sutaria R, Subramanian A, Burns B, Hafex H. Prevalence and management of ovarian venous insufficiency in the presence of leg venous insufficiency. Phlebology. 2007;22:29-33. [Crossref]  [PubMed]
  23. Haimov M, Baez A, Neff M, et al. Compliplications of arteriovenous fistulas for hemodialysis. Arch. Surg 1975;110:708-12. [Crossref]  [PubMed]
  24. Saremi F, Muresian H, Sánchez-Quintana D. Coronary veins: comprehensive CT-anatomic classification and review of variants and clinical implications. Radiographics. 2012;32:E1-32. [Crossref]  [PubMed]
  25. Zhang J. Stringer Ophthalmic and facial veins are not valveless. Clin Experiment Ophthalmol. 2010;38:502-10. [Crossref]  [PubMed]
  26. Vincent JR, Jones GT, Hill GB, van Rij AM. Failure of microvenous valves in small superficial veins is a key to the skin changes of venous insufficiency. J Vasc Surg 2011;54(6 suppl):62-9. [Crossref]  [PubMed]
  27. Pan-Chih, Huang AH, Dorsey LM: Hemodynamic significance of the coronary vein valves. Ann Thorac Surg. 1994;57(2):424. [Crossref]  [PubMed]
  28. Akşit E, Büyük B, Oğuz S. Histopathological changes in myocardial tissue due to coronary venous hypertension. Arch Med Sci. 2020;19(6):1714-20. [Crossref]  [PubMed]  [PMC]
  29. Hahn TL, Unthank JL, Lalka SG. Increased hindlimb leukocyte concentration in a chronic rodent model of venous hypertension. J Surg Res. 1999;81:38-41. [Crossref]  [PubMed]
  30. Herrick, SE, Sloan, P, McGurk, M, Freak, L, McCollum, CN, Ferguson, MW. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol. 1992;141:1085- 95.
  31. MacColl E, Khalil RA. Matrix metalloproteinases as regulators of vein structure and function: implications in chronic venous disease. J Pharmacol Exp Ther. 2015;355:410-28. [Crossref]  [PubMed]  [PMC]
  32. Zsotér T and Cronin RF. Venous distensibility in patients with varicose veins. Can Med Assoc J. 1966;94:1293-97.
  33. Yi C. Coronary sinus thrombosis: insights from a comprehensive literature review. Thromb J. 2025;23(1):24. [Crossref]  [PubMed]  [PMC]
  34. Challoumas D, Pericleous A, Dimitrakaki IA, Danelatos C, Dimitrakakis G. Coronary arteriovenous fistulae: a review. Int J Angiol. 2014;23:1-10. [Crossref]  [PubMed]  [PMC]
  35. Cohen B, Winer HE, Kronzon I. Echocardiography in persistent left superior vena cava and dilated coronary sinus. Am J Cardiol. 1979;44:158-63. [Crossref]  [PubMed]
  36. Snider AR, Dorts TA, Silverman NH. Venous anomalies of the coronary sinus: detection by M-mode, two dimensional and contrast echocardiography. Circulation. 1979;60:721-25. [Crossref]  [PubMed]
  37. Moey YYM, Ebin E, Marcu CB. Venous varices of the heart: a case report of spontaneous coronary sinus thrombosis with persistent left superior vena cava. Eur Heart J Case Rep 2018;2:yty092. [Crossref]
  38. Gupta A, Klintmalm GB, Kim PT. Ligating coronary vein varices: An effective treatment of "coronary vein steal" to increase portal flow in liver transplantation. Liver Transpl. 2016;22(7):1037-1039. [Crossref]  [PubMed]
  39. Aziz KU, Paul MH, Bharati S, Lev M, Shannon K. Echocardiographic features of total anomalous pulmonary venous drainage into the coronary sinus. Am J Cardiol. 1978;42:108-13. [Crossref]  [PubMed]
  40. Mahmud E, Raisinghani A, Keramati S, Auger W, Blanchard DG, DeMaria AN. Dilation of the coronary sinus on echocardiogram: prevalence and significance in patients with chronic pulmonary hypertension. J Am Soc Echocardiogr. 2001;14:44-9. [Crossref]  [PubMed]
  41. Lee MS, Shah AP, Dang N, Berman D, Forrester J, Prediman KS, et al. Coronary sinus is dilated and outwardly displaced in patients with mitral regurgitation: quantitative angiographic analysis. Catheter Cardiovasc Interv. 2006;67:490-4. [Crossref]  [PubMed]
  42. Lillehei CW, DeWall RA, Gott VL, Varco RL. The direct vision correction of calcific aortic stenosis by means of a pump-oxygenator and retrograde coronary si nus perfusion. Dis Chest. 1956;30:123-32. [Crossref]  [PubMed]
  43. Gott VL, Gonzalez JL, Zuhdi MN, Varco RL, Lillehei CW. Retrograde perfusion of the coronary sinus for direct vision aortic surgery. Surg Gynecol Obstet. 1957;104:319-28.
  44. Akşit E, Barutçu A, Şehitoğlu MH, Kıırlmaz B, Arslan M, Gazi E, et al. Association of abnormal coronary sinus reflux with coronary slow flow and importance of the Thebesian valve. Int J Cardiol. 2020;319:26-31. [Crossref]  [PubMed]
  45. Wang X, Nie SP. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc Diagn Ther. 2011;1(1):37-43.
  46. Fineschi M, Bravi A, Gori T. The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances. Int J Cardiol. 2008;127(3):358-61. [Crossref]  [PubMed]
  47. Sternheim D, Power DA, Samtani R, Kini A, Fuster V, Sharma S. Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021;78(22):2196-212. [Crossref]  [PubMed]
  48. Watanabe Y, Arakawa T, Kageyama I, Aizawa Y, Katsuji K, Miki A, et al. Gross anatomical study on the human myocardial bridges with special reference to the spatial relationship among coronary arteries, cardiac veins, and autonomic nerves. Clin Anat. 2016;29(3):333-41. [Crossref]  [PubMed]
  49. Meisel E, Pfeiffer D, Engelmann L, Tebbenjohanns J, Schubert B, Hahn S, et al. Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation. 2001;104(4):442-7. [Crossref]  [PubMed]
  50. Şengül FS, Ayyıldız P, Türkvatan A, Yıldız O, Güzeltaş A. Total or Partial? Rare Cases of Partial Anomalous Pulmonary Venous Return: Three Pulmonary Veins Connected to the Coronary Sinus. Balkan Med J. 2023;40(3):226-7. [Crossref]  [PubMed]  [PMC]
  51. Verma S, Verma S, Gupta P. Evaluation of Right Atrial-Coronary Sinus Pressure Gradients in Patients with Left Ventricular Dysfunction Undergoing Defibrillator Implantation. Description of the Phenomenon of Coronary Sinus Flow Reversal and its Incidence. J Med Clin Res & Rev. 2019; 3(5): 1-5. [Crossref]